Final Report of the National Academies' Human Embryonic Stem Cell Research Advisory Committee and 2010 Amendments to the National Academies' Guidelines for Human Embryonic Stem Cell Research (2010)
Chapter: Appendix B: Invited Participants at the August 7, 2009, Meeting of the Human Embryonic Stem Cell Research Advisory Committee
Appendix B
Invited Participants at the August 7, 2009, Meeting of the Human Embryonic Stem Cell Research Advisory Committee
GEORGE Q. DALEY, Samuel E. Lux IV Chair in Hematology and Director, Stem Cell Transplantation Program, Children’s Hospital Boston; Associate Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Investigator, Howard Hughes Medical Institute; and Past President, International Society for Stem Cell Research
DEBORAH A. HURSH, Senior Investigator, Division of Cellular and Gene Therapies, Center for Biologics Research and Review, U.S. Food and Drug Administration
JULIE KANESHIRO, Team Leader, Policy, Office for Human Research Protections, Department of Health and Human Services
STORY LANDIS, Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), and Chair, NIH Stem Cell Task Force
BERNARD LO, Professor of Medicine and Director of the Program in Medical Ethics, University of California, San Francisco
GEOFF LOMAX, Senior Officer to the Standards Working Group, California Institute for Regenerative Medicine
JOHN MCNEISH, Executive Director, Pfizer Regenerative Medicine
P. PEARL O’ROURKE, Director of Human Research Affairs, Partners HealthCare System, Boston; and Associate Professor of Pediatrics, Harvard Medical School
SEAN TIPTON, Past-President, Coalition for the Advancement of Medical Research; and Director of Public Affairs, American Society for Reproductive Medicine
